Press Releases

Press Releases

Date Title
February 9, 2023
UNITY Biotechnology to Host Investor Call to Review Data from the UBX1325 Program and Provide an Overview of the ENVISION Wet AMD Study
-Investor call with retinal expert Robert B. Bhisitkul , M.D., Ph.D., to be held on Tuesday, February 14, 2023 at 7:00 a.m. PT / 10:00 a.m. ET - -Complete 16- and 24-week safety and efficacy data from phase 2 ENVISION study in wet AMD expected in Q1 2023- SOUTH SAN FRANCISCO, Calif. , Feb.
January 18, 2023
UNITY Biotechnology Reports Granting of New Employment Inducement Award
SOUTH SAN FRANCISCO, Calif. , Jan. 18, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that from January 3, 2023 , through January 17, 2023 , the Compensation
Displaying 11 - 12 of 12